October 06, 2021 Precirix dosed first patients in Phase I/II clinical study evaluating CAM-H2 in HER2-positive metastatic cancer
October 05, 2021 Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.
September 28, 2021 Fusion Pharmaceuticals Appoints Mohit Rawat As President And Chief Business Officer
September 23, 2021 Strongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.